5′-O-[(4-Cyanophenyl)methyl]-2′,3′-O-(1-methylethylidene)adenosine
CAT:
804-HY-W604427
Size:
Inquire
For Laboratory Research Only. Not for Clinical or Personal Use.
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No
![5′-O-[(4-Cyanophenyl)methyl]-2′,3′-O-(1-methylethylidene)adenosine - image 1](/gentaur-product-1.webp)
![5′-O-[(4-Cyanophenyl)methyl]-2′,3′-O-(1-methylethylidene)adenosine - image 1](/gentaur-product-1.webp)
5′-O-[(4-Cyanophenyl)methyl]-2′,3′-O-(1-methylethylidene)adenosine
UNSPSC Description:
5′-O-[(4-Cyanophenyl)methyl]-2′,3′-O-(1-methylethylidene)adenosine is an adenosine analog. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. Its popular products are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1].Target Antigen:
Nucleoside Antimetabolite/AnalogType:
OligonucleotidesRelated Pathways:
Cell Cycle/DNA DamageApplications:
Cancer-programmed cell deathField of Research:
CancerAssay Protocol:
https://www.medchemexpress.com/5-o-4-cyanophenyl-methyl-2-3-o-1-methylethylidene-adenosine.htmlSolubility:
10 mM in DMSOSmiles:
NC1=NC=NC2=C1N=CN2[C@@H]3O[C@H](COCC4=CC=C(C#N)C=C4)[C@@H]5[C@H]3OC(C)(C)O5Molecular Weight:
422.44References & Citations:
[1]Man S, et al. Potential and promising anticancer drugs from adenosine and its analogs. Drug Discov Today. 2021 Jun;26(6):1490-1500.Shipping Conditions:
Room temperatureClinical Information:
No Development ReportedCAS Number:
1134156-51-6